Sparta, NJ
Sparta NJ 07871
mon-fri8:00 AM - 5:00 PM
saturdayClosed
sundayClosed
New Patients: For your convenience, please download, print out and complete the New Patient and Patient Medical History Forms and bring to your initial visit.
PATIENT FORMS
- General Consent for RCCA Services
- ACP Screener
- Pharmacy and Prescription Benefit Plan Information Form
- HIPAA acknowledgement
- Consultation Checklist & Radiology Policy
- New Jersey Immunization Information Systems (NJIIS) Consent to Participate
- Autorización de inscripción en el sistema de información sobre vacunación de nueva jersey
- Patient Finanical Assistance
Cancer Treatment Center in
Sparta, NJ
If you’ve been diagnosed with cancer, it’s important to choose the most effective therapy as part of your treatment plan. At Regional Cancer Care Associates in Sparta, NJ, we offer the latest in cancer treatment in a welcoming and friendly environment. Our oncologists and physicians work with you and your caregivers to more effectively devise the necessary treatment plan based on your medical history and symptoms. We also offer cancer support services and financial advocacy advising services, as part of our dedication to making the recovery process as straightforward as possible.
Regional Cancer Care Associates also conducts more than 300 clinical trials for new medications and diagnostic technologies. Volunteers are assured of a safely conducted environment with the information they need about the trial’s possible risks and rewards. Contact us today to learn more about our current trials.
Contact Us for More Information
Schedule an appointment at our office at 89 Sparta Avenue, Suite 130 in Sparta, NJ, 07871. You can get in touch with us through our online form.
Our cancer treatment services include:
Regional Cancer Care Associates is one of fewer than 200 medical practices in the country selected to participate in the Oncology Care Model (OCM); a recent Medicare initiative aimed at improving care coordination and access to and quality of care for Medicare beneficiaries undergoing chemotherapy treatment.